Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

Immunity

Volumn 9, Issue 5, 1998, Pages 711-720

  Bonfoco, Emanuela ^a   Stuart, Patrick M ^b   Brunner, Thomas ^c   Lin, Tesu ^a   Griffith, Thomas S ^b   Gao, Yakun ^b   Nakajima, Hiroo ^d   Henkart, Pierre A ^d   Ferguson, Thomas A ^b   Green, Douglas R ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FAS ANTIGEN; FAS LIGAND; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 17944394558     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80668-8     Document Type: Article

References (48)

1. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F., and Lynch, D.H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77.
2. Allison, J., Georgiou, H.M., Strasser, A., and Vaux, D.L (1997). Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. USA 94, 3943-3947.
3. Beller, D.I., Springer, T.A., and Schreiber, R.D. (1982). Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 156, 1000.
4. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., and Duke, R.C., (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
5. Brunner, T., Mogil, R.J., La Face, D., Yoo, N.J., Mahboubi, A., Echevarri, F., Martin, S.J., Force, W.R., Lynch, D.H., Ware, C.F., et al. (1995). Cell-autonomous Fas(CD95)/FasL interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373,441-444.
6. Brunner, T., Yoo, N.J., LaFace, D., Ware, C.F., and Green, D.R.. (1996). Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 8, 1017-1026.
7. Dhein, J., Walczac, H., Baumler, C., Debatin, K.M., and Krammer, P.M. (1995). Autocrine T-cell suicide mediated by APO-1/. Nature 373, 438-441.
8. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
9. French, LE., Hanhe, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C., and Tschopp, J. (1996). Fas and FasL in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 733, 335-343.
10. French, L.E., Wilson, A., Hahne, M., Viard, I., Tschopp, J., and MacDonald, H.R. (1997). Fas ligand expression is restricted to non-lymphoid thymic components in situ. J. Immunol. 159, 2196-2202.
11. Friesen, C., Herr, I., Krammer, P.H., and Debatin, K.M. (1996). Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2, 574-577.
12. Gonzalo, J.A., Mareno de Alboran, I., Ales-Martinez, J.E., Martinez, C., and Kroemer, G. (1992). Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway. Eur. J. Immunol. 22, 1007-1011.
13. Gratas, C., Tohma, Y., Van Meir, E.G., Klein, M., Tenan, M., Ishii, N., Tachibana, O., Kleihues, P., and Ohgaki, H. (1997). Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol. 7, 863-869.
14. Griffith, T.S., Brunner, T., Fletcher, S., Green, D.R., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
15. Griffith, T.S., Yu, X., Herndon, J.M., Green, D.R., and Ferguson, T.A. (1996). CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7-16.
16. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreirer, M., French, L.E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996). Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 22, 1363-1366.
17. Huang, L.G., Soldevila, G., Leeker, M., Flavell, R., and Crispe, I.N. (1994). The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1, 741-749.
18. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
19. Julius, M.H., Simpson, E., and Herzenberg, L.A. (1973). A rapid method for isolation of functional thymus derived murine lymphocytes. Eur. J. Immunol. 3, 645-647.
20. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D.R. (1998). DNA damaging agents induce expression of Fas-ligand and subsequent apoptosis in T lymphocytes via the stress-activated protein kinase pathway. Mol. Cell 1, 543-551.
21. Kawabe, Y., and Ochi, A. (1991). Programmed cell death and extrathymic reduction of VB8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349, 245-248.
22. Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
23. Kuschnaroff, LM., Valckx, D., Goebels, J., Rutgeerts, O., Heremans, H., Frayent, G., and Waer, M. (1997). Effect of treatment with cyclosporin A and anti-interferon gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice. Scand. J. Immunol. 46, 459-468.
24. Latinis, L., Carr, E., Peterson, L., Norian, S., Eliason, G., and Koretzky, J. (1997). Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158, 4602-4611.
25. Lu, L, Quiang, S., Hershberg, P.A., Rudert, W.A., Lynch, D.H., and Thomson, A.W. (1997). Fas ligand and B7 expression on dendritic cells provide counter regulatory signals for T cell survival and proliferation. J. Immunol. 158, 5676-5684.
26. Martz, E. (1975). Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. resolution and characterizations. J. Immunol. 115, 261-267.
27. Mogil, R.J., Gonzalez-Quintial, R., Miller, R., Mills, G., Theofilopoulus, A.N., and Green, D.R. (1995). Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7, 1451-1458.
28. Niehans, G.A., Brunner, T., Frizelle, S.P., Liston, J.C., Salerno, C.T., Knapp, D.J., Green, D.R., and Kratzke, R.A. (1997). Human lung carcinomas express Fas ligand. Cancer Res. 57, 1007-1012.
29. O'Connell, J., O'Sullivan, G.C., Collins, J.K., and Shanahan, F.J. (1996). The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184, 1075-1082.
30. Rao, A., Luo, C., and Hogan, P.G. (1997). Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747.
31. Refaeli, Y., Van Parijs, L., London, C.A., Tschopp, J., and Abbas, A.K. (1998). Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8, 615-623.
32. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fischer, A., and de Villartay, J.P. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
33. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 777, 195.
34. Seglen, P.O. (1973). Preparation of rat liver cells. Exp. Cell Res. 82, 391-398.
35. Shiraki, K., Tsuji, N., Shioda, T., Isselbacher, K.J., and Takahashi, H. (1997). Expression of Fas ligand in liver metastases of human colonie adenocarcinomas. Proc. Natl. Acad. Sci. USA 94, 6420-6425.
36. Simmons, D.M., Arizza, J.L., and Swanson, L.W. (1989). A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single stranded RNA probes. J. Histotechnol. 12, 169-181.
37. Singer, G.G., and Abbas, A.K. (1994). The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
38. Spangrude, G.J. (1994). Assessment of lymphocyte development in radiation bone marrow chimeras. In Current Protocols in Immunology, Vol. 1, J. Colligan, A. Krusbeek, D. Marguiles, E. Shevach, W. Strober, eds. (New York: Wiley and Sons), pp. 4.6.1-4.6.8.
39. Springer, T., Galfre, G., Secher, D.S., and Milstein, C. (1979). Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9, 301-306.
40. Stuart, P.M., Griffith, T.S., Usui, N., Pepose, J., Yu, X., and Ferguson, T.A. (1997). CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Inv. 99, 396-402.
41. Suss, G., and Shortman, K. (1996). A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183, 1789-1796.
42. Sytwu, H.K., Liblau, R.S., and McDevitt, H.O. (1996). The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5, 17-30.
43. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
44. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., and Kaneda, K. (1996). IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 757, 3967-3973.
45. Vanier, LE., and Proud'Homme, G. J. (1992). Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J. Exp. Med. 176, 37-46.
46. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
47. White, J., Herman, A., Pullen, A.M., Kubo, R., Kappler, J.W., and Marrack, P. (1989). The VB-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56, 27-35.
48. Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.P., Nicholl, J.K., Sutherland, G.R., Smith, T.D., Rauch, C., Smith, C.A., et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682.